Nosocomial Legionnaires' disease. Occurrence in recipients of bone marrow transplants.
Nosocomial pneumonia caused by Legionella pneumophila serogroup 1 occurred in five patients after bone marrow transplantation for hematologic malignancies. Two patients died as a result of the infection despite treatment with erythromycin. Serologic screening revealed no other cases of Legionnaires' disease in 40 consecutive recipients of bone marrow transplants, giving a frequency of infection of 13 percent. These five cases represent 23 percent of the pneumonia occurring in this group of patients. Patients undergoing bone marrow transplantation are highly susceptible to infectious complications. Legionnaires' disease must now be added to the list of pathogens infecting this group of patients. Erythromycin is not generally a part of standard empiric antibiotic regimens in febrile neutropenic patients, but appears to be a reasonable addition when pneumonia does not respond to conventional, empiric treatment. Even with appropriate therapy, Legionnaires' disease remains a highly lethal infection in immunocompromised hosts.
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D003428:Cross Infection / Q000209:etiology*; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007877:Legionnaires' Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000628:therapy; D007951:Leukemia, Myeloid / Q000150:complications* / Q000628:therapy; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000628:therapy; D011859:Radiography
D004917:Erythromycin